Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revising The Blueprint: FDA HQ Construction Nears Completion, But Some Planned Buildings On Hold

Executive Summary

The Life Sciences-Biodefense lab complex would remain on schedule for completion in FY 2014, but communications and logistical buildings included in the campus master plan would be on hold.

You may also be interested in...



US FDA Headquarters Parking Problem May Create Security Risk

GAO report says vehicle security system needs to be implemented, details challenges for employees handling sensitive information due to office sharing.

FDA Smart Growth Strategy: More Room At White Oak, Less In Budget

FDA's master plan update will study adding 3,800 employees to White Oak headquarters or elsewhere in area. Campus expansion is somewhat limited – it is bordered by commercial and residential areas to the north, south and west.

FDA Smart Growth Strategy: More Room At White Oak, Less In Budget

FDA's master plan update will study adding 3,800 employees to White Oak headquarters or elsewhere in area. Campus expansion is somewhat limited – it is bordered by commercial and residential areas to the north, south and west.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS054222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel